CorMedix Inc. logo

CorMedix Inc.

NASDAQ:CRMD

Overview | Financials
Company Name CorMedix Inc.
Symbol CRMD
Currency USD
Price 5.76
Market Cap 321,753,600
Dividend Yield 0%
52-week-range 2.57 - 7
Industry Biotechnology
Sector Healthcare
CEO Mr. Joseph Todisco MBA
Website https://www.cormedix.com

An error occurred while fetching data.

About CorMedix Inc.

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients

Related Stocks

Gamida Cell Ltd. logo

Gamida Cell Ltd.

GMDA

0.033 USD

Gritstone bio, Inc. logo

Gritstone bio, Inc.

GRTS

0.467 USD

ORIC Pharmaceuticals, Inc. logo

ORIC Pharmaceuticals, Inc.

ORIC

9.65 USD

Apyx Medical Corporation logo

Apyx Medical Corporation

APYX

1.3 USD

Cue Biopharma, Inc. logo

Cue Biopharma, Inc.

CUE

0.59 USD

Graphite Bio, Inc. logo

Graphite Bio, Inc.

GRPH

3.18 USD

Pieris Pharmaceuticals, Inc. logo

Pieris Pharmaceuticals, Inc.

PIRS

17.04 USD

Financials

Numbers are in millions USD

Numbers are in millions USD